|
ASX - By Stock
|
MSB |
Re:
Ann: Acquires CAR Platform for Precision-Enhanced Cell Products
|
|
stocksa
|
66 |
22K |
2 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
66
|
22K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Access to 221 U.S. Military Medical Centres
|
|
stocksa
|
108 |
22K |
6 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
108
|
22K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Acquires CAR Platform for Precision-Enhanced Cell Products
|
|
stocksa
|
66 |
22K |
1 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
66
|
22K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Access to 221 U.S. Military Medical Centres
|
|
stocksa
|
108 |
22K |
8 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
108
|
22K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stocksa
|
21K |
7.7M |
0 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
21K
|
7.7M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Acquires CAR Platform for Precision-Enhanced Cell Products
|
|
stocksa
|
66 |
22K |
3 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
66
|
22K
|
3
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Access to 221 U.S. Military Medical Centres
|
|
stocksa
|
108 |
22K |
6 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
108
|
22K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Acquires CAR Platform for Precision-Enhanced Cell Products
|
|
stocksa
|
66 |
22K |
9 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
66
|
22K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Access to 221 U.S. Military Medical Centres
|
|
stocksa
|
108 |
22K |
14 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
108
|
22K
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Acquires CAR Platform for Precision-Enhanced Cell Products
|
|
stocksa
|
66 |
22K |
9 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
66
|
22K
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
stocksa
|
912 |
290K |
2 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
912
|
290K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
stocksa
|
912 |
290K |
3 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
912
|
290K
|
3
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
stocksa
|
11 |
2.9K |
13 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
11
|
2.9K
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
1 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
0 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
1 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
0 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
1 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
2 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
1 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
0 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
860
|
333K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
1 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
288
|
85K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
4 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
288
|
85K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
2 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
288
|
85K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
288
|
85K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
1 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
288
|
85K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
stocksa
|
288 |
85K |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
288
|
85K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Features Commercial & Blockbuster Programs
|
|
stocksa
|
24 |
9.9K |
1 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
24
|
9.9K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia MD Responds to Questions Regarding AMPLICITY Trial
|
|
stocksa
|
82 |
22K |
10 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
82
|
22K
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Host R&D Day on April 8, 2026
|
|
stocksa
|
163 |
60K |
4 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
163
|
60K
|
4
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia MD Responds to Questions Regarding AMPLICITY Trial
|
|
stocksa
|
82 |
22K |
16 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
82
|
22K
|
16
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Therapeutics Halts Recruitment in AMPLICITY Trial
|
|
stocksa
|
99 |
30K |
3 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
99
|
30K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stocksa
|
21K |
7.7M |
0 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
21K
|
7.7M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Host R&D Day on April 8, 2026
|
|
stocksa
|
163 |
60K |
1 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
163
|
60K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Proposed issue of securities - MSB
|
|
stocksa
|
18 |
7.5K |
1 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
18
|
7.5K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Net Revenue for the Quarter Increases to US$30.3M
|
|
stocksa
|
80 |
32K |
2 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
80
|
32K
|
2
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Therapeutics Halts Recruitment in AMPLICITY Trial
|
|
stocksa
|
99 |
30K |
12 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
99
|
30K
|
12
|
|
|
ASX - By Stock
|
MSB |
Re:
R&D day
|
|
stocksa
|
155 |
63K |
1 |
03/04/26 |
| 03/04/26 |
ASX - By Stock
|
155
|
63K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
R&D day
|
|
stocksa
|
155 |
63K |
1 |
03/04/26 |
| 03/04/26 |
ASX - By Stock
|
155
|
63K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
stocksa
|
860 |
333K |
5 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
860
|
333K
|
5
|
|
|
ASX - By Stock
|
NVU |
Re:
Ann: Pitt Street Research Semiconductor Conference Presentation
|
|
stocksa
|
260 |
48K |
1 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
260
|
48K
|
1
|
|
|
ASX - By Stock
|
NVU |
Re:
NANOVEU General
|
|
stocksa
|
4.5K |
1.0M |
4 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
4.5K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
NVU |
Re:
Ann: Pitt Street Research Semiconductor Conference Presentation
|
|
stocksa
|
260 |
48K |
7 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
260
|
48K
|
7
|
|
|
ASX - By Stock
|
NVU |
Re:
Ann: Pitt Street Research Semiconductor Conference Presentation
|
|
stocksa
|
260 |
48K |
0 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
260
|
48K
|
0
|
|
|
ASX - By Stock
|
NVU |
Re:
Ann: Pitt Street Research Semiconductor Conference Presentation
|
|
stocksa
|
260 |
48K |
2 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
260
|
48K
|
2
|
|
|
ASX - By Stock
|
NVU |
Re:
NANOVEU General
|
|
stocksa
|
4.5K |
1.0M |
4 |
31/03/26 |
| 31/03/26 |
ASX - By Stock
|
4.5K
|
1.0M
|
4
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Reports Improved Responses & Survival in ACCENT trial
|
|
stocksa
|
427 |
123K |
1 |
30/03/26 |
| 30/03/26 |
ASX - By Stock
|
427
|
123K
|
1
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Reports Improved Responses & Survival in ACCENT trial
|
|
stocksa
|
427 |
123K |
8 |
30/03/26 |
| 30/03/26 |
ASX - By Stock
|
427
|
123K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stocksa
|
21K |
9.0M |
15 |
29/03/26 |
| 29/03/26 |
ASX - By Stock
|
21K
|
9.0M
|
15
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stocksa
|
21K |
7.7M |
2 |
26/03/26 |
| 26/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|